Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.
Sponheim
Jon
J
Department of Internal Medicine, Asker and Baerum Hospital, Vestre Viken Hospital Trust, Rud, Norway.
Pollheimer
Jürgen
J
Olsen
Trine
T
Balogh
Johanna
J
Hammarström
Clara
C
Loos
Tamara
T
Kasprzycka
Monika
M
Sørensen
Dag Reidar
DR
Nilsen
Hogne Røed
HR
Küchler
Axel M
AM
Vatn
Morten H
MH
Haraldsen
Guttorm
G
D000818:Animals; D001706:Biopsy; D016022:Case-Control Studies; D002478:Cells, Cultured; D003093:Colitis, Ulcerative / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D003106:Colon / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D003424:Crohn Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D000067596:Interleukin-33; D007378:Interleukins / Q000235:genetics* / Q000378:metabolism; D058628:Myofibroblasts / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D011070:Poly I-C / Q000494:pharmacology; D051381:Rats; D051196:Toll-Like Receptor 3 / Q000819:agonists; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014945:Wound Healing / Q000235:genetics / Q000502:physiology
C506536:IL33 protein, human; D000067596:Interleukin-33; D007378:Interleukins; C495344:TLR3 protein, human; D051196:Toll-Like Receptor 3; D016212:Transforming Growth Factor beta; D011070:Poly I-C